TrialPediatric blood & cancer2015

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.

AeRang Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.